FDA Approved: CIBINQO — Supplemental Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for CIBINQO (abrocitinib) filed by U.S. Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

SUPPL AP for CIBINQO (ABROCITINIB)